Northwestern Mutual and Alex’s Lemonade Stand fund eight young investigators

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NORTHWESTERN MUTUAL, through its foundation, will fund four young investigator grants for childhood cancer research. The awards support Alex’s Lemonade Stand Foundation’s young investigator program.

The addition of these four research projects results in eight total funded research projects this year, an $800,000 commitment. Each researcher receives a total grant of $100,000 over two-years. Four of the recipients received their initial funding last year.

The eight grant recipients are: Charalambos Kaittanis, of Memorial Sloan Kettering Cancer Center, for studying the effects of radiation therapy; Laura Schuettpelz, of Washington University at St. Louis, for harvesting bone marrow; Shizhen Zhu, of the Mayo Clinic, for neuroblastoma development; Cigall Kadoch, of Dana Farber Institute, for sarcoma tumor research; Jeffrey Huo, of The Johns Hopkins University School of Medicine, for studying the epigenetic origins of the retinoblastoma tumor-initiating cell; Carl Koschmann, of University of Michigan, for therapy for pediatric glioblastoma; Katherine Tarlock, of Fred Hutchinson Cancer Research Center, for therapeutic strategies for leukemia; and Mireya Velasquez, of Baylor College of Medicine, for research for leukemia and lymphoma.

YOU MAY BE INTERESTED IN

In this week's episode of The Cancer Letter Podcast, editor and publisher Paul Goldberg, and associate editor Jacquelyn Cobb revisit two of last week’s most-read stories: the growing recognition that early-onset colorectal cancer requires a new diagnostic mindset, and the life and legacy of Maura Gillison, the scientist whose discovery that most head and neck cancers are driven by HPV transformed the field. 
For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login